Get a glimpse into our company and investor data—powered by the PitchBook Platform
Developer of anti-idiopathic pulmonary ﬁbrosis drug. The company develops anti-idiopathic pulmonary ﬁbrosis drug which is used in curing inﬂuenza infection, solid tumors and helps in wound healing.
You’re viewing a free company profile from the PitchBook Platform. To explore New Amsterdam Sciences’s full profile, request a free trial.
© 2019 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.